{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T06:41:55Z","timestamp":1788244915548,"version":"build-2803163510"},"reference-count":120,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Aromatase, the key enzyme in estrogen biosynthesis, converts androstenedione to estrone and testosterone to estradiol. The enzyme is expressed in various tissues such as ovary, placenta, bone, brain, skin, and adipose tissue. Aromatase enzyme is encoded by a single gene<jats:italic>CYP 19A1<\/jats:italic>and its expression is controlled by tissue-specific promoters. Aromatase mRNA is primarily transcribed from promoter I.4 in normal breast tissue and physiological levels of aromatase are found in breast adipose stromal fibroblasts. Under the conditions of breast cancer, as a result of the activation of a distinct set of aromatase promoters (I.3, II, and I.7) aromatase expression is enhanced leading to local overproduction of estrogen that promotes breast cancer. Aromatase is considered as a potential target for endocrine treatment of breast cancer but due to nonspecific reduction of aromatase activity in other tissues, aromatase inhibitors (AIs) are associated with undesirable side effects such as bone loss, and abnormal lipid metabolism. Inhibition of aromatase expression by inactivating breast tumor-specific aromatase promoters can selectively block estrogen production at the tumor site. Although several synthetic chemical compounds and nuclear receptor ligands are known to inhibit the activity of the tumor-specific aromatase promoters, further development of more specific and efficacious drugs without adverse effects is still warranted. Plants are rich in chemopreventive agents that have a great potential to be used in chemotherapy for hormone dependent breast cancer which could serve as a source for natural AIs. In this brief review, we summarize the studies on phytochemicals such as biochanin A, genistein, quercetin, isoliquiritigenin, resveratrol, and grape seed extracts related to their effect on the activation of breast cancer-associated aromatase promoters and discuss their aromatase inhibitory potential to be used as safer chemotherapeutic agents for specific hormone-dependent breast cancer.<\/jats:p>","DOI":"10.1186\/1477-7827-9-91","type":"journal-article","created":{"date-parts":[[2011,6,22]],"date-time":"2011-06-22T07:27:22Z","timestamp":1308727642000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Potential utility of natural products as regulators of breast cancer-associated aromatase promoters"],"prefix":"10.1186","volume":"9","author":[{"given":"Shabana I","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikhlas A","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry A","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asok K","family":"Dasmahapatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,6,21]]},"reference":[{"key":"870_CR1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1055\/s-2004-823023","volume":"22","author":"ER Simpson","year":"2004","unstructured":"Simpson ER: Aromatase: biologic relevance of tissue specific expression. Semin Reprod Med. 2004, 22: 11-23.","journal-title":"Semin Reprod Med"},{"key":"870_CR2","doi-asserted-by":"crossref","first-page":"19385","DOI":"10.1016\/S0021-9258(19)47313-4","volume":"264","author":"GD Means","year":"1989","unstructured":"Means GD, Mahendroo MS, Corbin CJ, Mathis JM, Powell FE, Mendelson CR, Simpson ER: Structural analysis of the gene encoding human aromatase cytochrome P-450, the enzyme responsible for estrogen biosynthesis. J Biol Chem. 1989, 264: 19385-19391.","journal-title":"J Biol Chem"},{"key":"870_CR3","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0960-0760(97)80013-1","volume":"61","author":"Y Zhao","year":"1997","unstructured":"Zhao Y, Agarwal VR, Mendelson CR, Simpson ER: Transcriptional regulation of CYP 19 gene (aromatase) expression in adipose stromal cells in primary culture. J Steroid Biochem Mol Biol. 1997, 61: 203-210. 10.1016\/S0960-0760(97)80013-1.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"870_CR4","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1146\/annurev.physiol.64.081601.142703","volume":"64","author":"ER Simpson","year":"2002","unstructured":"Simpson ER, Clyne C, Rubin G, Boon WC, Robertson K, Britt K, Speed C, Jones M: Aromatase-a brief overview. Annu Rev Physiol. 2002, 64: 93-127. 10.1146\/annurev.physiol.64.081601.142703.","journal-title":"Annu Rev Physiol"},{"issue":"7226","key":"870_CR5","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nature07614","volume":"457","author":"D Ghosh","year":"2009","unstructured":"Ghosh D, Griswold J, Erman M, Pangborn W: Structural basis for androgen specificity and oestrogen synthesis in human aromatase. Nature. 2009, 457 (7226): 219-223. 10.1038\/nature07614.","journal-title":"Nature"},{"key":"870_CR6","first-page":"141","volume":"1","author":"M Milani","year":"2009","unstructured":"Milani M, Jha G, Potter DA: Anastrozole use in early stage breast cancer of post-menopausal women. Clin Med Ther. 2009, 1: 141-156.","journal-title":"Clin Med Ther"},{"issue":"24","key":"870_CR7","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1056\/NEJMra023246","volume":"348","author":"IE Smith","year":"2003","unstructured":"Smith IE, Dowsett M: Aromatase inhibitors in breast cancer. N Engl J Med. 2003, 348 (24): 2431-2442. 10.1056\/NEJMra023246.","journal-title":"N Engl J Med"},{"issue":"3-5","key":"870_CR8","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0960-0760(03)00360-1","volume":"86","author":"ER Simpson","year":"2003","unstructured":"Simpson ER: Sources of estrogen and their importance. J Steroid Biochem Mol Biol. 2003, 86 (3-5): 225-230. 10.1016\/S0960-0760(03)00360-1.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"870_CR9","first-page":"126","volume":"61","author":"I Czajka-Oraniec","year":"2010","unstructured":"Czajka-Oraniec I, Simpson ER: Aromatase research and its clinical significance. Endokrynol Pol. 2010, 61: 126-134.","journal-title":"Endokrynol Pol"},{"key":"870_CR10","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/0006-291X(90)91954-Q","volume":"166","author":"N Harada","year":"1990","unstructured":"Harada N, Yamada K, Saito K, Kibe N, Dohmae S, Takagi Y: Structural characterization of the human estrogen synthetase (aromatase) gene. Biochem Biophys Res Commun. 1990, 166: 365-372. 10.1016\/0006-291X(90)91954-Q.","journal-title":"Biochem Biophys Res Commun"},{"key":"870_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00008571-199602000-00002","volume":"6","author":"DR Nelson","year":"1996","unstructured":"Nelson DR, Koymans L, Kamataki T, Stegeman JJ, Feyereisen R, Waxman DJ, Waterman MR, Gotoh O, Coon MJ, Estabrook RW, Gunsalus IC, Nebert DW: P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics. 1996, 6: 1-42. 10.1097\/00008571-199602000-00002.","journal-title":"Pharmacogenetics"},{"key":"870_CR12","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1124\/pr.57.3.6","volume":"57","author":"SE Bulun","year":"2005","unstructured":"Bulun SE, Lin Z, Imir G, Amin S, Demura M, Yilmaz B, Martin R, Utsunomiya H, Thung S, Gurates B, Tamura M, Langoi D, Deb S: Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment. Pharmacol Rev. 2005, 57: 359-383. 10.1124\/pr.57.3.6.","journal-title":"Pharmacol Rev"},{"key":"870_CR13","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/978-0-387-78818-0_8","volume":"630","author":"SE Bulun","year":"2008","unstructured":"Bulun SE, Simpson ER: Aromatase expression in women's cancer. Adv Exp Med Biol. 2008, 630: 112-132. 10.1007\/978-0-387-78818-0_8.","journal-title":"Adv Exp Med Biol"},{"key":"870_CR14","doi-asserted-by":"crossref","unstructured":"Chen D, Reierstad S, Lu M, Lin Z, Ishikawa H, Bulun SE: Regulation of breast cancer-associated aromatase promoters. Cancer Lett. 2009, 15-27. 273","DOI":"10.1016\/j.canlet.2008.05.038"},{"key":"870_CR15","doi-asserted-by":"publisher","first-page":"3476","DOI":"10.2174\/092986710792927877","volume":"17","author":"J Jiao","year":"2010","unstructured":"Jiao J, Xiang H, Liao Q: Recent advancement in nonsteroidal aromatase inhibitors for treatment of estrogen-dependent breast cancer. Curr Med Chem. 2010, 17: 3476-3487. 10.2174\/092986710792927877.","journal-title":"Curr Med Chem"},{"key":"870_CR16","doi-asserted-by":"crossref","first-page":"11276","DOI":"10.1016\/S0021-9258(18)99159-3","volume":"266","author":"MS Mahendroo","year":"1991","unstructured":"Mahendroo MS, Means GD, Mendelson CR, Simpson ER: Tissue-specific expression of human P-450AROM. The promoter responsible for expression in adipose tissue is different from that utilized in placenta. J Biol Chem. 1991, 266: 11276-11281.","journal-title":"J Biol Chem"},{"key":"870_CR17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1096\/fasebj.11.1.9034163","volume":"11","author":"ER Simpson","year":"1997","unstructured":"Simpson ER, Michael MD, Agarwal VR, Hinshelwood MM, Bulun SE, Zhao Y: Expression of the CYP19 (aromatase) gene: an unsual case of alternative promoter usage. FASEB J. 1997, 11: 29-36.","journal-title":"FASEB J"},{"key":"870_CR18","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1210\/me.2002-0123","volume":"16","author":"S Sebastian","year":"2002","unstructured":"Sebastian S, Takayama K, Shozu M, Bulun SE: Cloning and characterization of a novel endothelial promoter of the human CYP19 (aromatase P450) gene that is up-regulated in breast cancer tissue. Mol Endocrinol. 2002, 16: 2243-2254. 10.1210\/me.2002-0123.","journal-title":"Mol Endocrinol"},{"key":"870_CR19","doi-asserted-by":"crossref","unstructured":"Bulun SE, Takayama K, Suzuki T, Sasano H, Yilmaz B, Sebastian S: Organization of the human aromatase p450 (CYP19) gene. Semin Reprod Med. 2004, 5-9. 22","DOI":"10.1055\/s-2004-823022"},{"key":"870_CR20","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1210\/me.9.3.340","volume":"9","author":"Y Zhao","year":"1995","unstructured":"Zhao Y, Mendelson CR, Simpson ER: Characterization of the sequences of human CYP19 (aromatase) gene that mediate regulation by glucocorticoids in adipose stomal cells and fetal hepatocytes. Mol Endocrinol. 1995, 9: 340-349. 10.1210\/me.9.3.340.","journal-title":"Mol Endocrinol"},{"key":"870_CR21","doi-asserted-by":"publisher","first-page":"16449","DOI":"10.1074\/jbc.270.27.16449","volume":"270","author":"Y Zhao","year":"1995","unstructured":"Zhao Y, Nichols JE, Bulun SE, Mendelson CR, Simpson ER: Aromatase p450 gene expression in human adipose tissue. Role of Jak\/STAT pathway in regulation of the adipose-specific promoter. J Biol chem. 1995, 270: 16449-16457. 10.1074\/jbc.270.27.16449.","journal-title":"J Biol chem"},{"key":"870_CR22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/j.1749-6632.2009.03705.x","volume":"1155","author":"SE Bulun","year":"2009","unstructured":"Bulun SE, Lin Z, Zhao H, Lu M, Amin S, Reierstad S, Chen D: Regulation of aromatase expression in breast cancer tissue. Ann NY Acad Sci. 2009, 1155: 121-131. 10.1111\/j.1749-6632.2009.03705.x.","journal-title":"Ann NY Acad Sci"},{"key":"870_CR23","first-page":"2328","volume":"61","author":"J Zhou","year":"2001","unstructured":"Zhou J, Gurates B, Yang S, Sebastian S, Bulun SE: Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT\/enhancer binding protein beta. Cancer Res. 2001, 61: 2328-2334.","journal-title":"Cancer Res"},{"key":"870_CR24","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1210\/jc.81.6.2344","volume":"81","author":"T Utsumi","year":"1996","unstructured":"Utsumi T, Harada N, Maruta M, Takagi Y: Presence of alternatively spliced transcripts of aromatase gene in human breast cancer. J Clin Endocrinol Metab. 1996, 81: 2344-2349. 10.1210\/jc.81.6.2344.","journal-title":"J Clin Endocrinol Metab"},{"key":"870_CR25","doi-asserted-by":"publisher","first-page":"3843","DOI":"10.1210\/jc.81.11.3843","volume":"81","author":"VR Agarwal","year":"1996","unstructured":"Agarwal VR, Bulun SE, Leitch M, Rohrich R, Simpson ER: Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients. J Clin Endocrinol Metab. 1996, 81: 3843-3849. 10.1210\/jc.81.11.3843.","journal-title":"J Clin Endocrinol Metab"},{"key":"870_CR26","volume-title":"Cancer statistics","author":"American Cancer Society","year":"2006","unstructured":"American Cancer Society: Cancer statistics. 2006, [http:\/\/www.cancer.org\/Research\/CancerFactsFigures\/CancerFactsFigures\/index]"},{"key":"870_CR27","first-page":"272","volume":"7","author":"IARC (International Agency of Research on Cancer)","year":"1987","unstructured":"IARC (International Agency of Research on Cancer): Overall evaluation of Carcinogenicity: An updating of IARC Monographs Volumes 1 to 42. IARC Monogr Eval Carcinog Risks Hum Suppl. 1987, 7: 272-310.","journal-title":"IARC Monogr Eval Carcinog Risks Hum Suppl"},{"key":"870_CR28","first-page":"474","volume":"72","author":"IARC (International Agency for Research on Cancer)","year":"1999","unstructured":"IARC (International Agency for Research on Cancer): Hormonal concentration and postmenopausal hormone therapy. IARC Monogr Eval Carcinog Risks Hum. 1999, 72: 474-530.","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"key":"870_CR29","first-page":"63","volume":"1766","author":"E Cavalieri","year":"2006","unstructured":"Cavalieri E, chakravarti D, Guttenplan J, Hart E, Ingle J, Jankowiak R, Muti P, Rogan E, Russo J, Santen R, Sutter T: Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention. Biochim Biophys Acta. 2006, 1766: 63-78.","journal-title":"Biochim Biophys Acta"},{"key":"870_CR30","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1056\/NEJMra050776","volume":"354","author":"JD Yager","year":"2006","unstructured":"Yager JD, Davidson NE: Estrogen carcinogenesis in breast cancer. N Engl J Med. 2006, 354: 270-282. 10.1056\/NEJMra050776.","journal-title":"N Engl J Med"},{"key":"870_CR31","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1210\/jcem-46-1-146","volume":"46","author":"C Longcope","year":"1978","unstructured":"Longcope C, Pratt JH, Schneider SH, Fineberg SE: Aromatization of androgens by muscle and adipose tissue in vivo. J Clin Endocrinol Metab. 1978, 46: 146-152. 10.1210\/jcem-46-1-146.","journal-title":"J Clin Endocrinol Metab"},{"key":"870_CR32","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1359\/jbmr.1997.12.9.1416","volume":"12","author":"H Sasano","year":"1997","unstructured":"Sasano H, Uzuki M, Sawai T, Nagura H, Matsunaga G, Kashimoto O, Harada N: Aromatase in human bone tissue. J Bone Miner Res. 1997, 12: 1416-1423. 10.1359\/jbmr.1997.12.9.1416.","journal-title":"J Bone Miner Res"},{"key":"870_CR33","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s10549-007-9788-0","volume":"111","author":"A Subramanian","year":"2008","unstructured":"Subramanian A, Salhab M, Mokbel K: Oestrogen producing enzymes and mammary carcinogenesis: a review. Breast Cancer Res Treat. 2008, 111: 191-202. 10.1007\/s10549-007-9788-0.","journal-title":"Breast Cancer Res Treat"},{"key":"870_CR34","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1161\/01.RES.84.11.1285","volume":"84","author":"N Harada","year":"1999","unstructured":"Harada N, Sasano H, Murakami H, Ohkuma T, Nagura H, Takagi Y: Localized expression of aromatase in human vascular tissues. Cir Res. 1999, 84: 1285-1291.","journal-title":"Cir Res"},{"key":"870_CR35","doi-asserted-by":"publisher","first-page":"4589","DOI":"10.1210\/en.142.11.4589","volume":"142","author":"ER Simpson","year":"2001","unstructured":"Simpson ER, Davis SR: Minireview: aromatase and the regulation of estrogen biosynthesis-some new perspectives. Endocrinology. 2001, 142: 4589-4594. 10.1210\/en.142.11.4589.","journal-title":"Endocrinology"},{"key":"870_CR36","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/j.1749-6632.1996.tb16246.x","volume":"784","author":"LA Castagnetta","year":"1996","unstructured":"Castagnetta LA, Lo Casto M, Granata OM, Polito L, Calabro M, Lo Bue A, Bellavia V, Carruba G: Estrogen content and metabolism in human breast tumor tissues and cells. Ann NY Acad Sci. 1996, 784: 314-324. 10.1111\/j.1749-6632.1996.tb16246.x.","journal-title":"Ann NY Acad Sci"},{"key":"870_CR37","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/0960-0760(90)90465-W","volume":"37","author":"Y Miki","year":"1990","unstructured":"Miki Y, Suzuki T, Sasano H: Controversies of aromatase localization in human breast cancer-stromal versus parenchymal cells. J Steroid Biochem Mol Biol. 1990, 37: 1055-1059. 10.1016\/0960-0760(90)90465-W.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"870_CR38","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1507\/endocrj.K07E-053","volume":"55","author":"T Suzuki","year":"2008","unstructured":"Suzuki T, Miki Y, Akahira J-I, Moriya T, Ohuchi N, Sasano H: Aromatase in human breast carcinoma as a key regulator of intratumoral sex steroid concentrations. Endocrine J. 2008, 55: 455-463. 10.1507\/endocrj.K07E-053.","journal-title":"Endocrine J"},{"key":"870_CR39","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/0960-0760(90)90465-W","volume":"37","author":"WR Miller","year":"1990","unstructured":"Miller WR, Anderson TJ, Jack WJ: Relationship between tumor aromatase acitivity, tumor characteristics and response to therapy. J steroid Biochem Mol Biol. 1990, 37: 1055-1059. 10.1016\/0960-0760(90)90465-W.","journal-title":"J steroid Biochem Mol Biol"},{"key":"870_CR40","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.biopha.2003.09.007","volume":"57","author":"T Suzuki","year":"2003","unstructured":"Suzuki T, Moriya T, Ishida T, Ohuchi N, Sasano H: Intracrine mechanism of estrogen synthesis in breast cancer. Biomed Pharmacother. 2003, 57: 460-462. 10.1016\/j.biopha.2003.09.007.","journal-title":"Biomed Pharmacother"},{"key":"870_CR41","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1309\/4WV79N2GHJ3X1841","volume":"123","author":"M Nadji","year":"2005","unstructured":"Nadji M, Gomez-Fernandez C, Ganjei-Azar P, Morales AR: Immunohistochemistry of estrogen and projesteron receptors reconsidered: experience with 5,993 breast cancers. Am J Clin pathol. 2005, 123: 21-27. 10.1309\/4WV79N2GHJ3X1841.","journal-title":"Am J Clin pathol"},{"key":"870_CR42","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.2174\/138955709789055207","volume":"9","author":"T Wang","year":"2009","unstructured":"Wang T, You Q, Huang FS, Xiang H: Recent advances in selective estrogen receptor modulators for breast cancer. Mini Rev Med Chem. 2009, 9: 1191-1201. 10.2174\/138955709789055207.","journal-title":"Mini Rev Med Chem"},{"key":"870_CR43","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1210\/er.2004-0015","volume":"26","author":"RW Brueggemeier","year":"2005","unstructured":"Brueggemeier RW, Hackett JC, Diaz-Cruz ES: Aromatase inhibitors in the treatment of breast cancer. Endocr Rev. 2005, 26: 331-345. 10.1210\/er.2004-0015.","journal-title":"Endocr Rev"},{"key":"870_CR44","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2147\/TCRM.S1566","volume":"4","author":"JM Nabholtz","year":"2008","unstructured":"Nabholtz JM: Long-term safety of aromatase inhibitors in the treatment of breast cancer. Ther Clin Risk Manag. 2008, 4: 189-204.","journal-title":"Ther Clin Risk Manag"},{"key":"870_CR45","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1158\/1078-0432.CCR-10-1595","volume":"17","author":"BJ Edwards","year":"2011","unstructured":"Edwards BJ, Raisch DW, Shankaran V, McKoy JM, Gradishar W, Bunta AD, Samaras AT, Boyle SN, Bennett CL, West DP, Guise TA: Cancer therapy associated bone loss: implications for hip fractures in mid-life women with breast cancer. Clin cancer Res. 2011, 17: 560-568. 10.1158\/1078-0432.CCR-10-1595.","journal-title":"Clin cancer Res"},{"key":"870_CR46","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.amjmed.2010.02.028","volume":"123","author":"G Mazziotti","year":"2010","unstructured":"Mazziotti G, Canalis E, Giustina A: Drug-induced osteoporosis: mechanisms and clinical implications. Am J Med. 2010, 123: 877-884. 10.1016\/j.amjmed.2010.02.028.","journal-title":"Am J Med"},{"key":"870_CR47","first-page":"1299","volume":"7","author":"Y Murata","year":"2000","unstructured":"Murata Y, Ogawa Y, Saibara T, Nishioka A, Fujiwara Y, Fukumoto M, Inomata T, Enzan H, Onishi S, Yoshida S: Unrecognized hepatic steatosis and non-alcoholic steatohepatitis in adjuvant tamoxifen for breast cancer patients. Oncol Rep. 2000, 7: 1299-1304.","journal-title":"Oncol Rep"},{"key":"870_CR48","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/0168-8278(95)80316-5","volume":"23","author":"HC Pinto","year":"1995","unstructured":"Pinto HC, Baptista A, Camilo ME, de Costa EB, Valente A, de Moura MC: Tamoxifen-associated steatohepatitis report of three cases. J Hepatol. 1995, 23: 95-97. 10.1016\/0168-8278(95)80316-5.","journal-title":"J Hepatol"},{"key":"870_CR49","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/S0140-6736(05)74872-8","volume":"353","author":"KA Oien","year":"1999","unstructured":"Oien KA, Moffat D, Curry GW, Dickson J, Habeshaw T, Mills PR, MacSween RN: Cirrhosis with steatohepatitis after adjuvant tamoxifen. Lancet. 1999, 353: 36-37. 10.1016\/S0140-6736(05)74872-8.","journal-title":"Lancet"},{"key":"870_CR50","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1210\/jc.83.6.2214","volume":"83","author":"E Simpson","year":"1998","unstructured":"Simpson E, Davis S: Why do the clinical sequelae of estrogen deficiency affect women more than men?. J Clin Endocrinol Metab. 1998, 83: 2214-10.1210\/jc.83.6.2214.","journal-title":"J Clin Endocrinol Metab"},{"key":"870_CR51","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/S1043-2760(00)00254-X","volume":"11","author":"E Simpson","year":"2000","unstructured":"Simpson E, Rubin G, Clyne C, Robertson K, Donnell L, Jones M, Davis S: The role of local estrogen biosynthesis in the males and females. Trends Endocrinol Metab. 2000, 11: 184-188. 10.1016\/S1043-2760(00)00254-X.","journal-title":"Trends Endocrinol Metab"},{"key":"870_CR52","doi-asserted-by":"publisher","first-page":"11762","DOI":"10.1158\/0008-5472.CAN-05-2792","volume":"65","author":"R Safi","year":"2005","unstructured":"Safi R, Kovacic A, Gaillard S, Mutara ER, Simpson ER, McDonnell DP, Clyne CD: Coactivation of liver receptor homologue-1 by peroxisome proliferator-activated receptor gamma coactivator-1 aplha on aromatase promoter II and its inhibition by activated retinoid \u00d7 receptor suggest a novel target for breast-specific antiestrogen therapy. Cancer Res. 2005, 65: 11762-11770. 10.1158\/0008-5472.CAN-05-2792.","journal-title":"Cancer Res"},{"key":"870_CR53","doi-asserted-by":"crossref","first-page":", 2863","DOI":"10.1210\/endo.143.8.8932","volume":"143","author":"GL Rubin","year":"2002","unstructured":"Rubin GL, Duong JH, Clyne CD, Speed CJ, Murata Y, Gong C, Simpson ER: Ligands of the peroxisomal proliferator-activated receptor gamma and the retinoid \u00d7 receptor inhibit aromatase cytochrome P450 (CYP19) expression mediated by promoter II in human breast adipose. Endocrinology. 2002, 143: , 2863-2871.","journal-title":"Endocrinology"},{"issue":"suppl 2","key":"870_CR54","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1002\/dmrr.252","volume":"18","author":"HE Lebovitz","year":"2002","unstructured":"Lebovitz HE: Differentiating members of the thiazolidinedione class: a focus on safety. Diabetes Metab Res Rev. 2002, 18 (suppl 2): S23-S29.","journal-title":"Diabetes Metab Res Rev"},{"key":"870_CR55","first-page":"1","volume":"7","author":"R Sharma","year":"2005","unstructured":"Sharma R, Sharma R, Verma U, Bhat NK: Novel drugs targeting retinoic acid receptors. JK Science. 2005, 7: 1-2.","journal-title":"JK Science"},{"key":"870_CR56","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1074\/jbc.M508498200","volume":"281","author":"S Deb","year":"2006","unstructured":"Deb S, Zhou J, Amin SA, Imir AG, Yimaz MB, Lin Z, Bulun SE: A novel role of sodium butyrate in the regulation of cancer-associated aromatase promoters I.3 and II by disrupting transcriptional complex in breast adipose fibroblasts. J Biol Chem. 2006, 281: 2585-2597.","journal-title":"J Biol Chem"},{"key":"870_CR57","first-page":"1471","volume":"20","author":"UH Weidle","year":"2000","unstructured":"Weidle UH, Grossmann A: Inhibition of histone deacetylases: a new strategy to target epigenetic modifications of anticancer treatment. Anticancer Res. 2000, 20: 1471-1485.","journal-title":"Anticancer Res"},{"key":"870_CR58","doi-asserted-by":"publisher","first-page":"8914","DOI":"10.1158\/0008-5472.CAN-06-4751","volume":"67","author":"D Chen","year":"2007","unstructured":"Chen D, Reierstad S, Lin Z, Lu M, Brooks C, Li N, Innes J, Bulun SE: Prostaglandin E (2) induces breast cancer related aromatase promoters via activation of p38 and c-jun NH(2)-terminal kinase in adipose fibroblast. Cancer Res. 2007, 67: 8914-8922. 10.1158\/0008-5472.CAN-06-4751.","journal-title":"Cancer Res"},{"key":"870_CR59","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1517\/13543784.15.6.721","volume":"15","author":"SD Gore","year":"2006","unstructured":"Gore SD, Carducci MA: Modifying histones to tame cancer: clinical development of sodium phenylbutyrate and other histone deacetylase inhibitors. Expert Opin Investig drugs. 2006, 15: 721-727. 10.1517\/13543784.15.6.721.","journal-title":"Expert Opin Investig drugs"},{"key":"870_CR60","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1517\/13543784.15.6.721","volume":"15","author":"M Braddock","year":"2006","unstructured":"Braddock M, Murray C: 10th anniversary inflammation and immune diseases Drug Discovery and Development Summit. 20-21 March 2006, New Brunswick, USA. Expert Opin Investig Drugs. 2006, 15: 721-727. 10.1517\/13543784.15.6.721.","journal-title":"Expert Opin Investig Drugs"},{"key":"870_CR61","doi-asserted-by":"crossref","first-page":"646","DOI":"10.2174\/187152008785133092","volume":"8","author":"MJ Balunas","year":"2008","unstructured":"Balunas MJ, Su B, Brueggemeier RW, Kinghorn AD: Natural products as aromatase inhibitors. Anticancer Agents Med Chem. 2008, 8: 646-682.","journal-title":"Anticancer Agents Med Chem"},{"key":"870_CR62","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1021\/np040016t","volume":"67","author":"JW Daly","year":"2004","unstructured":"Daly JW: Marine toxins and nonmarine toxins: convergence or symbiotic organisms. J Nat Prod. 2004, 67: 1211-1215. 10.1021\/np040016t.","journal-title":"J Nat Prod"},{"key":"870_CR63","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/nature03194","volume":"432","author":"J Cardy","year":"2004","unstructured":"Cardy J, Walsh C: Lessons from natural molecules. Nature. 2004, 432: 829-837. 10.1038\/nature03194.","journal-title":"Nature"},{"key":"870_CR64","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1039\/b514294f","volume":"25","author":"MS Butler","year":"2008","unstructured":"Butler MS: Natural products to drugs: natural product-derived compounds in clinical trials. Nat Prod Rep. 2008, 25: 475-516. 10.1039\/b514294f.","journal-title":"Nat Prod Rep"},{"key":"870_CR65","first-page":"1280","volume":"10","author":"DJ Newman","year":"2009","unstructured":"Newman DJ, Cragg GM: Microbial antitumor drugs: natural products of microbial origin as anticancer agents. Curr Opin Investig Drugs. 2009, 10: 1280-1296.","journal-title":"Curr Opin Investig Drugs"},{"key":"870_CR66","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.tips.2010.02.005","volume":"31","author":"AM Mayer","year":"2010","unstructured":"Mayer AM, Glaser KB, Cuevas C, Jacobs RS, Kem W, Little RD, McIntosh JM, Newman DJ, Potts BC, Shuster DE: The odyssey of marine pharmaceuticals: a current pipeline perspective. Trends Pharmacol Sci. 2010, 31: 255-265. 10.1016\/j.tips.2010.02.005.","journal-title":"Trends Pharmacol Sci"},{"key":"870_CR67","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.1021\/cr900019j","volume":"109","author":"GM Cragg","year":"2009","unstructured":"Cragg GM, Grothaus PG, Newman DJ: Impact of natural products on developing new anti-cancer agents. Chem Rev. 2009, 109: 3012-3042. 10.1021\/cr900019j.","journal-title":"Chem Rev"},{"key":"870_CR68","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.fitote.2010.11.017","volume":"82","author":"DM Eisenberg","year":"2011","unstructured":"Eisenberg DM, Harris ES, Littlefield BA, Cao S, Craycroft JA, Scholten R, Bayliss P, Fu Y, Wang W, Qiao Y, Zhao Z, Chen H, Liu Y, Kaptchuk T, Hahn WC, Wang X, Roberts T, Shamu CE, Clardy J: Developing a library of authenticated Traditional Chinese medicinal (TCM) plants for systematic biological evaluation-rationale, methods and preliminary results from a Sino-American collaboration. Fitoterapia. 2011, 82: 17-33. 10.1016\/j.fitote.2010.11.017.","journal-title":"Fitoterapia"},{"key":"870_CR69","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1055\/s-2005-864092","volume":"71","author":"JP Basly","year":"2005","unstructured":"Basly JP, Lavier MC: Dietary phytoestrogens: potential selective estrogen enzyme modulators?. Planta Med. 2005, 71: 287-294. 10.1055\/s-2005-864092.","journal-title":"Planta Med"},{"key":"870_CR70","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1051\/rnd:2005055","volume":"45","author":"KM Edmunds","year":"2005","unstructured":"Edmunds KM, Holloway AC, Crankshaw DJ, Agarwal SK, Foster WG: The effects of dietary phytoestrogens on aromatase activity in human endometrial stromal cells. Reprod Nutr Dev. 2005, 45: 709-720. 10.1051\/rnd:2005055.","journal-title":"Reprod Nutr Dev"},{"key":"870_CR71","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1093\/humrep\/deg125","volume":"18","author":"SA Whitehead","year":"2003","unstructured":"Whitehead SA, Lacey M: Phytoestrogens inhibit aromatase but not 17\u03b2-hydroxysteroid dehydrogenase (HSD) type 1 in human granulosa-luteal cells: evidence for FSH induction of 17\u03b2-HSD. Human Repro. 2003, 18: 487-494. 10.1093\/humrep\/deg125.","journal-title":"Human Repro"},{"key":"870_CR72","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1677\/erc.1.01159","volume":"13","author":"S Rice","year":"2006","unstructured":"Rice S, Whitehead SA: Phytoestrogens and breast cancer-promoters or protectors?. Endocrine-Related Cancer. 2006, 13: 995-1015. 10.1677\/erc.1.01159.","journal-title":"Endocrine-Related Cancer"},{"key":"870_CR73","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/ardp.200800174","volume":"342","author":"Z Bal","year":"2009","unstructured":"Bal Z, Gust R: Breast cancer, estrogen receptor and ligands. Arch Pharm Chem Life Sci. 2009, 342: 133-149. 10.1002\/ardp.200800174.","journal-title":"Arch Pharm Chem Life Sci"},{"key":"870_CR74","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/S0950-351X(98)80007-4","volume":"12","author":"H Adlercreutz","year":"1998","unstructured":"Adlercreutz H: Epidemiology of phytoestrogens. Bailliers Clin Endocrinol Metab. 1998, 12: 605-623. 10.1016\/S0950-351X(98)80007-4.","journal-title":"Bailliers Clin Endocrinol Metab"},{"key":"870_CR75","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1080\/10408390591000541","volume":"46","author":"SN Nichenametla","year":"2006","unstructured":"Nichenametla SN, Taruscio TG, Barney DL, Exon JH: A review of the effects of mechanisms of polyphenolics in cancer. Crit Rev Food Sci Nutr. 2006, 46: 161-183. 10.1080\/10408390591000541.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"870_CR76","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1507\/endocrj.53.7","volume":"53","author":"T Usui","year":"2006","unstructured":"Usui T: Pharmaceutical prospects of phytoestrogens. Endocrine J. 2006, 53: 7-20. 10.1507\/endocrj.53.7.","journal-title":"Endocrine J"},{"key":"870_CR77","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1289\/ehp.10538","volume":"166","author":"SM Mense","year":"2008","unstructured":"Mense SM, Hei TK, Ganju RK, Bhat HK: Phytoestrogens and breast cancer prevention: possible mechanisms of action. Environ Health Persp. 2008, 166: 426-433.","journal-title":"Environ Health Persp"},{"key":"870_CR78","first-page":"241","volume":"19-20","author":"G Ursin","year":"1994","unstructured":"Ursin G, Bernstein L, Pike MG: Breast cancer. Cancer Surv. 1994, 19-20: 241-264.","journal-title":"Cancer Surv"},{"key":"870_CR79","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1023\/A:1021381101632","volume":"77","author":"PH Peeters","year":"2003","unstructured":"Peeters PH, Keinan-Boker L, van der Schouw YT, Grobbee DE: Phytoestrogens and breast cancer risk. Review of the epidemiological evidence. Breast cancer Res Treat. 2003, 77: 171-183. 10.1023\/A:1021381101632.","journal-title":"Breast cancer Res Treat"},{"key":"870_CR80","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1289\/ehp.9810685","volume":"106","author":"YC Kao","year":"1998","unstructured":"Kao YC, Zhou C, Sherman M, Laughton CA, Chen S: A site-directed mutagenesis study Molecular basis of the inhibition of human aromatase (estrogen synthetase) by flavone and isoflavone phytoestrogens. Environ Health Perspect. 1998, 106: 85-92.","journal-title":"Environ Health Perspect"},{"key":"870_CR81","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S0960-0760(03)00361-3","volume":"86","author":"S Chen","year":"2003","unstructured":"Chen S, Zhang F, Sherman MA, Kijima I, Cho M, Yuan YC, Toma Y, Osawa Y, Zhou D, Eng ET: Structure-function studies of aromatase and its inhibitors: a progress report. J Steroid Biochem Mol Biol. 2003, 86: 231-237. 10.1016\/S0960-0760(03)00361-3.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"870_CR82","doi-asserted-by":"publisher","first-page":"8466","DOI":"10.1016\/j.bmc.2008.08.034","volume":"16","author":"S Paoletta","year":"2008","unstructured":"Paoletta S, Steventon GB, Wildeboer D, Ehrman TM, Hylands PJ, Barlow DJ: Screening of herbal constituents for aromatase inhibitory activity. Bioorganic Med Chem. 2008, 16: 8466-8470. 10.1016\/j.bmc.2008.08.034.","journal-title":"Bioorganic Med Chem"},{"key":"870_CR83","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.2741\/3493","volume":"14","author":"S Adam","year":"2009","unstructured":"Adam S, Chen S: Phytochemicals for breast cancer prevention by targeting aromatase. Front Biosci. 2009, 14: 3846-3863.","journal-title":"Front Biosci"},{"key":"870_CR84","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.jep.2008.09.016","volume":"120","author":"J Zhao","year":"2008","unstructured":"Zhao J, Dasmahapatra AK, Khan SI, Khan IA: Anti-aromatase activity of the constituents from damiana (Turnera diffusa). J Ethnopharmacol. 2008, 120: 387-393. 10.1016\/j.jep.2008.09.016.","journal-title":"J Ethnopharmacol"},{"key":"870_CR85","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1055\/s-0030-1250169","volume":"76","author":"MC Balunas","year":"2010","unstructured":"Balunas MC, Kinghorn AD: Natural compounds with aromatase inhibitory activity: an update. Planta Med. 2010, 76: 1087-1093. 10.1055\/s-0030-1250169.","journal-title":"Planta Med"},{"key":"870_CR86","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1093\/toxsci\/kfh257","volume":"82","author":"JT Sanderson","year":"2004","unstructured":"Sanderson JT, Hordijk J, Denison MS, Springsteel MF, Nantz MH, van den Berg M: Induction and inhibition of aromatase (CYP19) activity by natural and synthetic flavonoid compounds in H295R human adrenocortical carcinoma cells. Toxicol Sci. 2004, 82: 70-79. 10.1093\/toxsci\/kfh257.","journal-title":"Toxicol Sci"},{"key":"870_CR87","doi-asserted-by":"crossref","unstructured":"Kijima I, Phung S, Hur G, Kwok SL, Chen S: Grape seed extract is an aromatase inhibitor and a suppressor of aromatase expression. Cancer Res. 2006, 5960-5967. 66","DOI":"10.1158\/0008-5472.CAN-06-0053"},{"key":"870_CR88","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1017\/S0007114507811974","volume":"99","author":"Y Wang","year":"2008","unstructured":"Wang Y, Gho WM, Chan FL, Chen S, Leung LK: The red clover (trifolium pretense) isoflavone biochenin A inhibits aromatase activity and expression. Brit J Nutr. 2008, 99: 303-310.","journal-title":"Brit J Nutr"},{"key":"870_CR89","doi-asserted-by":"crossref","unstructured":"Ye L, Chan MY, Leung LK: The soy isoflavone genistein induces estrogen synthesis in the extragonadal pathway. Mol Cell Endocrionol. 2009, 73-80. 302","DOI":"10.1016\/j.mce.2009.01.003"},{"key":"870_CR90","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1002\/ijc.24046","volume":"124","author":"L Ye","year":"2009","unstructured":"Ye L, Gho WM, Chan FL, Chen S, Leung LK: Dietary administration of the licorice flavonoid isoliquiritigenin deters the growth of MCF-7 cells overespressing aromatase. Int J can. 2009, 124: 1028-1036. 10.1002\/ijc.24046.","journal-title":"Int J can"},{"key":"870_CR91","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/toxsci\/kfj190","volume":"92","author":"Y Wang","year":"2006","unstructured":"Wang Y, Lee KW, Chan FL, Chen S, Leung LK: The red wine polyphenol reseveratrol displays bilevel inhibition on aromatase in breast cancer cells. Toxicol Sci. 2006, 92: 71-77. 10.1093\/toxsci\/kfj190.","journal-title":"Toxicol Sci"},{"key":"870_CR92","first-page":"1092","volume-title":"Chem Indus","author":"GS Pope","year":"1953","unstructured":"Pope GS, Elcoate PV, Simpson SA, Andrews DG: Isolation of an oestrogenic isoflavone (biochanin A) from red clover. Chem Indus. 1953, 1092"},{"key":"870_CR93","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1751-0813.1946.tb15473.x","volume":"22","author":"HW Bennets","year":"1946","unstructured":"Bennets HW, Underwood EJ, Shier FL: A specific breeding problem of sheep on subterranean clover pastures in western Australia. Aust Vet J. 1946, 22: 2-12. 10.1111\/j.1751-0813.1946.tb15473.x.","journal-title":"Aust Vet J"},{"key":"870_CR94","first-page":"151","volume":"5","author":"HR Linder","year":"1976","unstructured":"Linder HR: Occurrence of anabolic agents in plants and their importance. Environ Qual saf Suppl. 1976, 5: 151-158.","journal-title":"Environ Qual saf Suppl"},{"key":"870_CR95","first-page":"124","volume":"36","author":"K Kallela","year":"1984","unstructured":"Kallela K, Heinonen K, saloniemi H: Plant oestrogens; the cause of decresed fertility in cows. A case report. Nord Vet Med. 1984, 36: 124-129.","journal-title":"Nord Vet Med"},{"key":"870_CR96","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3181\/00379727-208-43825","volume":"208","author":"H Saloniemi","year":"1995","unstructured":"Saloniemi H, Wahala K, Nykanen-Kurki P, Kallela K, Saastamoinen I: Phytoestrogen content and estrogenic effect of legume fodder. Proc Soc Exp Biol Med. 1995, 208: 13-17.","journal-title":"Proc Soc Exp Biol Med"},{"key":"870_CR97","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1289\/ehp.02110743","volume":"110","author":"K Almstrup","year":"2002","unstructured":"Almstrup K, Fernandez MF, Petersen JH, Olea N, Skakkebaek NE, Leffers H: Dual effects of phytoestrogens results in u-shaped dose-response curves. Environ Health perspect. 2002, 110: 743-748. 10.1289\/ehp.02110743.","journal-title":"Environ Health perspect"},{"key":"870_CR98","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/0378-4347(94)00390-4","volume":"662","author":"AA Franke","year":"1994","unstructured":"Franke AA, Custer LJ: High-performance liquid chromatographic assay of isoflavonoids and coumestrol from human urine. J chromatogram B Biomed Appl. 1994, 662: 47-60. 10.1016\/0378-4347(94)00390-4.","journal-title":"J chromatogram B Biomed Appl"},{"key":"870_CR99","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1006\/abio.1996.0025","volume":"233","author":"W Mazur","year":"1996","unstructured":"Mazur W, Fotsis T, Wahala K, Ojala S, Salakka A, Adlercreutz H: Isotope dilution gas chromatographic-mass spectrometric method for the determination of isoflavonoids, coumestrol, and lignans in food samples. Anal Biochem. 1996, 233: 169-180. 10.1006\/abio.1996.0025.","journal-title":"Anal Biochem"},{"key":"870_CR100","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.1161\/01.ATV.17.12.3392","volume":"17","author":"PJ Nestel","year":"1997","unstructured":"Nestel PJ, Yamashita T, sasahara T, Pomeroy S, Dart A, Komesaroff P, Owen A, Abbey M: Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women. Arterioscler thromb Vasc Biol. 1997, 17: 3392-3398. 10.1161\/01.ATV.17.12.3392.","journal-title":"Arterioscler thromb Vasc Biol"},{"key":"870_CR101","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.maturitas.2005.09.011","volume":"54","author":"J Manonai","year":"2006","unstructured":"Manonai J, Songchitsomboon S, Chanda K, Hong JH, Komindr S: The effect of a soy-rich diet on urogenital atrophy: a randomized, cross-over trial. Maturitas. 2006, 54: 135-140. 10.1016\/j.maturitas.2005.09.011.","journal-title":"Maturitas"},{"key":"870_CR102","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s13148-010-0011-5","volume":"1","author":"SM Meeran","year":"2010","unstructured":"Meeran SM, Ahmad A, Tollefsbol TO: Epigenetic targets of bioactive dietary components for cancer prevention and therapy. Clin Epigenetics. 2010, 1: 101-116. 10.1007\/s13148-010-0011-5.","journal-title":"Clin Epigenetics"},{"key":"870_CR103","doi-asserted-by":"crossref","first-page":"777s","DOI":"10.1093\/jn\/125.3_Suppl.777S","volume":"125","author":"S Barnes","year":"1995","unstructured":"Barnes S: Effect of genistein on in vitro and in vivo model of cancer. J nutr. 1995, 125: 777s-783s.","journal-title":"J nutr"},{"key":"870_CR104","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.taap.2004.08.009","volume":"204","author":"S Myllymaki","year":"2005","unstructured":"Myllymaki S, Haavisto T, Vainio M, Toppari J, Paranko J: In vitro effects of diethylstilbestrol, genistein, 4-tert-butylphenol, and 4-tert-octylphenol on steroidogenic activity of isolated mature rat ovarian follicles. Toxicol Appl Pharmacol. 2005, 204: 69-80. 10.1016\/j.taap.2004.08.009.","journal-title":"Toxicol Appl Pharmacol"},{"key":"870_CR105","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1093\/toxsci\/kfh257","volume":"82","author":"JT Sanderson","year":"2004","unstructured":"Sanderson JT, Hordijk J, Denison MS, Springsteel MF, Nantz MH, van der Berg M: Induction and inhibition of aromatase (CYP19) activity by natural and synthetic flavonoid compounds in H295R human adrenocortical carcinoma cells. Toxicol Sci. 2004, 82: 70-79. 10.1093\/toxsci\/kfh257.","journal-title":"Toxicol Sci"},{"key":"870_CR106","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1093\/carcin\/bgn161","volume":"29","author":"YH Ju","year":"2008","unstructured":"Ju YH, Doerge DR, Woodling KA, Hartman JA, Kwak J, Helferich WG: Dietary genistein negates the inhibitory effect of latrozole on the growth of aromatase-expressing estrogen-dependent human breast cancer cells (MCF-7Ca) in vivo. Carcinogenesis. 2008, 29: 2162-2168. 10.1093\/carcin\/bgn161.","journal-title":"Carcinogenesis"},{"key":"870_CR107","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/0960-0760(95)00261-8","volume":"57","author":"C Pelissero","year":"1996","unstructured":"Pelissero C, Lenczowski MJ, Chinzi D, Davail-Cuisset B, Sumpter JP, Fostier A: Eflavonoids on aromatase activity, an in vitro study. J steroid Biochem Mol boil. 1996, 57: 215-223. 10.1016\/0960-0760(95)00261-8.","journal-title":"J steroid Biochem Mol boil"},{"key":"870_CR108","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jsbmb.2006.06.021","volume":"101","author":"S Rice","year":"2006","unstructured":"Rice S, Mason HD, Whitehead SA: Phytoestrogens and their low dose combinations inhibit mRNA expression and activity of aromatase in human granulosa-luteal cells. J Steroid Biochem Mol Biol. 2006, 101: 216-225. 10.1016\/j.jsbmb.2006.06.021.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"870_CR109","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1126\/science.6474163","volume":"225","author":"JT Kellis","year":"1984","unstructured":"Kellis JT, Vickery LE: Inhibition of human estrogen synthase (aromatase) by flavones. Science. 1984, 225: 1032-1034. 10.1126\/science.6474163.","journal-title":"Science"},{"key":"870_CR110","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/0960-0760(94)90030-2","volume":"50","author":"C Wang","year":"1994","unstructured":"Wang C, Makela T, hase T, Kurzer MS: Lignans and flavonoids inhibit aromatase enzyme in human preadipocytes. J steroid Biochem Mol Biol. 1994, 50: 205-212. 10.1016\/0960-0760(94)90030-2.","journal-title":"J steroid Biochem Mol Biol"},{"key":"870_CR111","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.taap.2007.03.016","volume":"221","author":"JA van Meeuwen","year":"2007","unstructured":"van Meeuwen JA, Korthagen PC, de Jong PC, Piersma AH, van den Berg M: (Anti)estrogenic effects of phytochemicals on human primary mammary fibroblasts, MCF-7 cells and their co-culture. Toxicol appl Pharmacol. 2007, 221: 372-383. 10.1016\/j.taap.2007.03.016.","journal-title":"Toxicol appl Pharmacol"},{"key":"870_CR112","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.prostaglandins.2006.07.003","volume":"81","author":"JR Prosperi","year":"2006","unstructured":"Prosperi JR, Robertson FM: Cyclooxygenase-2 directly regulates gene expression of P450 Cyp19 aromatase promoter regions pII, p1.3, and pI.7 and estradiol production in human breast tumor cells. Prostaglandins Other Lipid Mediat. 2006, 81: 55-70. 10.1016\/j.prostaglandins.2006.07.003.","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"870_CR113","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jsbmb.2009.11.009","volume":"118","author":"RW Brueggemeier","year":"2010","unstructured":"Brueggemeier RW, Su B, Darby MV, Sugimoto Y: Selective regulation of aromatase expression for drug discovery. J Steroid Biochem Mol Biol. 2010, 118: 207-210. 10.1016\/j.jsbmb.2009.11.009.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"870_CR114","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.mce.2010.02.035","volume":"321","author":"KC Knower","year":"2010","unstructured":"Knower KC, To SQ, Simpson ER, Clyne CD: Epigenetic mechanisms resulting CYP19 transcription in human breast adipose fibroblasts. Mol Cell Endocrinol. 2010, 321: 123-130. 10.1016\/j.mce.2010.02.035.","journal-title":"Mol Cell Endocrinol"},{"key":"870_CR115","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1042\/BJ20051802","volume":"395","author":"G Fujii","year":"2006","unstructured":"Fujii G, nakamura Y, Tsukamoto D, Ito M, Shiba T, Takamatsu N: CpG methylation at the USF-binding site is important for the liver-specific transcription of the chipmunk HP-27 gene. Biochem J. 2006, 395: 203-209. 10.1042\/BJ20051802.","journal-title":"Biochem J"},{"key":"870_CR116","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1038\/sj.emboj.7601148","volume":"25","author":"B Jones","year":"2006","unstructured":"Jones B, Chen J: Inhibition of INF-gamma transcription by site-specific methylation during T helper cell development. EMBO J. 2006, 25: 2443-2452. 10.1038\/sj.emboj.7601148.","journal-title":"EMBO J"},{"key":"870_CR117","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/jjco\/hyi088","volume":"35","author":"K Miyamoto","year":"2005","unstructured":"Miyamoto K, Ushijima T: Diagnostic and therapeutic applications of epigenetics. Jap J Clin Oncol. 2005, 35: 293-301. 10.1093\/jjco\/hyi088.","journal-title":"Jap J Clin Oncol"},{"key":"870_CR118","first-page":"7563","volume":"63","author":"MZ Fang","year":"2003","unstructured":"Fang MZ, Wang Y, Ai N, Hou Z, Sun Y, Lu H, Welsh W, Yang CS: Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res. 2003, 63: 7563-7570.","journal-title":"Cancer Res"},{"key":"870_CR119","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/j.1753-4887.2004.tb00041.x","volume":"62","author":"SB Moyers","year":"2004","unstructured":"Moyers SB, Kumar NB: Green tea polyphenols and cancer chemoprevention: multiple mechanisms and endpoints for phase II trials. Nutr Rev. 2004, 62: 204-211. 10.1111\/j.1753-4887.2004.tb00041.x.","journal-title":"Nutr Rev"},{"issue":"suppl 1","key":"870_CR120","first-page":"S16","volume":"57","author":"H Krik","year":"2008","unstructured":"Krik H, Cefalu WT, Ribnicky D, Liu Z, Eilertsen KJ: Botanicals as epigenetic modulators for mechanisms contributing to development of metabolic syndrome. Metab Clinic Exp. 2008, 57 (suppl 1): S16-S23.","journal-title":"Metab Clinic Exp"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-7827-9-91.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T12:58:04Z","timestamp":1741265884000},"score":1,"resource":{"primary":{"URL":"https:\/\/rbej.biomedcentral.com\/articles\/10.1186\/1477-7827-9-91"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,21]]},"references-count":120,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["870"],"URL":"https:\/\/doi.org\/10.1186\/1477-7827-9-91","relation":{},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,21]]},"assertion":[{"value":"24 March 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"91"}}